Comparison of the oral bioavailability and tissue disposition of monensin and salinomycin in chickens and turkeys
Article first published online: 26 MAY 2011
© 2011 Blackwell Publishing Ltd
Journal of Veterinary Pharmacology and Therapeutics
Volume 35, Issue 1, pages 73–81, February 2012
How to Cite
HENRI, J., MAURICE, R., POSTOLLEC, G., DUBREIL-CHENEAU, E., ROUDAUT, B., LAURENTIE, M. and SANDERS, P. (2012), Comparison of the oral bioavailability and tissue disposition of monensin and salinomycin in chickens and turkeys. Journal of Veterinary Pharmacology and Therapeutics, 35: 73–81. doi: 10.1111/j.1365-2885.2011.01285.x
- Issue published online: 6 JAN 2012
- Article first published online: 26 MAY 2011
- (Paper received 28 May 2010; accepted for publication 13 February 2011)
Henri, J., Maurice, R., Postollec, G., Dubreil-Cheneau, E., Roudaut, B., Laurentie, M., Sanders, P. Comparison of the oral bioavailability and tissue disposition of monensin and salinomycin in chickens and turkeys. J. Vet. Pharmacol. Therap. 35, 73–81.
The current study describes the pharmacokinetic parameters of two carboxylic polyether ionophores: monensin in turkeys and salinomycin in chickens. These data can be used to understand and predict the occurrence of undesirable residues of coccidiostats in edible tissues of these animal species. Special attention is paid to the distribution of residues between the different edible tissues during and at the end of the treatment period. For the bioavailability studies, monensin was administered to turkeys intravenously, in the left wing vein, at a dose of 0.4 mg /kg and orally at a dose of 20 mg /kg. Salinomycin was administered to chickens intravenously, in the left wing vein, at a dose of 0.25 mg /kg and orally at a dose of 2.5 mg /kg. Residue studies were carried out with supplemented feed at the rate of 100 mg /kg of feed for monensin in turkeys and 70 mg /kg for salinomycin in chickens, respectively. Coccidiostats had a low bioavailability in poultry (around 30% for monensin in chickens, around 1% for monensin in turkeys and around 15% for salinomycin in chickens). Monensin in chickens had a longer terminal half-life (between 3.07 and 5.55 h) than both monensin in turkeys (between 1.36 and 1.55 h) and salinomycin in chickens (between 1.33 and 1.79 h). The tissue /plasma partition coefficients showed a higher affinity of both monensin and salinomycin for fat, followed by liver and muscle tissue. The depletion data showed a fairly rapid elimination of coccidiostats in all the tissues after cessation of treatment. According to the results of depletion studies, a withdrawal period of 1 day seems sufficient to avoid undesirable exposure of consumers.